Boston Scientific

BTG

Interventional medicine

£3.3bn ($4.24bn)

Summit Partners

Sound Inpatient Physician Holdings

Acute care services

$2.2bn

Bought the controlling interest that was previously held by Fresenius

Platinum Equity

LifeScan – J&J's diabetes business

Diabetes

$2.1bn

Roche (Switzerland)

Flatiron Health

Oncology management software

$1.9bn

The outstanding 87.4%

Medtronic

Mazor Robotics (Israel)

Surgical robotics

$1.6bn

CDH Investments (China)

Sirtex (Australia)

Oncology

$1.4bn

Outbid a $1.3bn offer from Varian in the same year

Stryker

K2M

Orthopedics

$1.4bn

Veritas Capital

GE Healthcare's value-based health-care division

$1.05bn

Medtech Rises To Challenge Of Meeting Infinite Heath Care Demand With Finite Resources

More from Business